EP4698682A1 - Prognoseverfahren für nichtmetastatischen weiblichen brustkrebs - Google Patents

Prognoseverfahren für nichtmetastatischen weiblichen brustkrebs

Info

Publication number
EP4698682A1
EP4698682A1 EP24736723.8A EP24736723A EP4698682A1 EP 4698682 A1 EP4698682 A1 EP 4698682A1 EP 24736723 A EP24736723 A EP 24736723A EP 4698682 A1 EP4698682 A1 EP 4698682A1
Authority
EP
European Patent Office
Prior art keywords
stage
breast cancer
risk
risk score
developing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP24736723.8A
Other languages
English (en)
French (fr)
Inventor
Paola PARRELLA
Andrea FONTANA
Raffaela BARBANO
Tommaso Mazza
Barbara PASCULLI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fondazione Di Religione E Di Culto "casa Sollievo Della Sofferenza" Opera Di San Pio Da Pietrelcina
Original Assignee
Fondazione Di Religione E Di Culto "casa Sollievo Della Sofferenza" Opera Di San Pio Da Pietrelcina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fondazione Di Religione E Di Culto "casa Sollievo Della Sofferenza" Opera Di San Pio Da Pietrelcina filed Critical Fondazione Di Religione E Di Culto "casa Sollievo Della Sofferenza" Opera Di San Pio Da Pietrelcina
Publication of EP4698682A1 publication Critical patent/EP4698682A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP24736723.8A 2023-06-22 2024-06-21 Prognoseverfahren für nichtmetastatischen weiblichen brustkrebs Pending EP4698682A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT202300012870 2023-06-22
PCT/EP2024/067439 WO2024261242A1 (en) 2023-06-22 2024-06-21 Prognostic method for non-metastatic female breast cancer

Publications (1)

Publication Number Publication Date
EP4698682A1 true EP4698682A1 (de) 2026-02-25

Family

ID=87801106

Family Applications (1)

Application Number Title Priority Date Filing Date
EP24736723.8A Pending EP4698682A1 (de) 2023-06-22 2024-06-21 Prognoseverfahren für nichtmetastatischen weiblichen brustkrebs

Country Status (5)

Country Link
EP (1) EP4698682A1 (de)
KR (1) KR20260025789A (de)
CN (1) CN121794400A (de)
AU (1) AU2024314529A1 (de)
WO (1) WO2024261242A1 (de)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103820562B (zh) 2005-08-01 2015-05-13 俄亥俄州立大学研究基金会 用于乳腺癌的诊断、预后和治疗的基于MicroRNA的方法和组合物
EP2613149B1 (de) 2007-07-25 2014-09-17 University Of Louisville Research Foundation, Inc. Exosomassoziierte microRNA als Diagnosemarker
ES2936256T3 (es) 2008-02-01 2023-03-15 Massachusetts Gen Hospital Uso de microvesículas en el diagnóstico, y pronóstico de enfermedades y afecciones médicas
WO2011127219A1 (en) 2010-04-06 2011-10-13 Caris Life Sciences Luxembourg Holdings Circulating biomarkers for disease
US8859202B2 (en) 2012-01-20 2014-10-14 The Ohio State University Breast cancer biomarker signatures for invasiveness and prognosis
EP3444362B1 (de) * 2014-05-02 2020-12-09 Ruprecht-Karls-Universität Heidelberg Zirkulierende mirnas als früherkennungsmarker und prognostischer marker
MX390160B (es) 2015-12-04 2025-03-20 Instituto Nac De Medicina Genomica Método de pronóstico en cáncer de mama.
CN105603117B (zh) * 2016-03-31 2019-04-09 北京泱深生物信息技术有限公司 miR-3613用于区分肺鳞癌转移与非转移的miRNA标志物
IL278221B2 (en) * 2018-05-02 2025-03-01 Castle Biosciences Inc Methods for diagnosing and treating patients with cutaneous squamous cell carcinoma

Also Published As

Publication number Publication date
KR20260025789A (ko) 2026-02-24
AU2024314529A1 (en) 2025-12-18
WO2024261242A1 (en) 2024-12-26
CN121794400A (zh) 2026-04-03

Similar Documents

Publication Publication Date Title
JP7042784B2 (ja) 遺伝子発現を用いた前立腺癌の予後を定量化する方法
Filella et al. Emerging biomarkers in the diagnosis of prostate cancer
JP6908571B2 (ja) 前立腺癌の予後を定量化するための遺伝子発現プロフィールアルゴリズムおよび試験
US11309059B2 (en) Medical prognosis and prediction of treatment response using multiple cellular signalling pathway activities
US11220716B2 (en) Methods for predicting the prognosis of breast cancer patient
Shen et al. MicroRNA signatures in diagnosis and prognosis of cutaneous T-cell lymphoma
Rahbari et al. Identification of differentially expressed microRNA in parathyroid tumors
Hofbauer et al. A urinary microRNA (miR) signature for diagnosis of bladder cancer
CN102333887B (zh) 用于检测gi癌转移的方法
CN116064800A (zh) 通过检测微小RNA(miRNA)的表达水平来确定患乳腺癌的风险的方法
US20180142303A1 (en) Methods and compositions for diagnosing or detecting lung cancers
WO2012066451A1 (en) Prognostic and predictive gene signature for colon cancer
CN113039289B (zh) 预测黑色素瘤转移和患者预后的基因特征
CN118043484A (zh) 用于乳腺癌早期检测的循环微rna组及其方法
US20150322533A1 (en) Prognosis of breast cancer patients by monitoring the expression of two genes
CN103687963A (zh) 利用与转移相关的多基因标签来确定肝细胞癌的预后的方法
TW201827603A (zh) 用於膀胱癌預後的生物標記物組合
CN110592223B (zh) 一种NSCLC的诊断和预后标记物hsa_circRNA_012515的应用
AU2024314529A1 (en) Prognostic method for non-metastatic female breast cancer
US20150329911A1 (en) Nucleic acid biomarkers for prostate cancer
US20240093306A1 (en) Micro rna liver cancer markers and uses thereof
KR102450582B1 (ko) 바이오마커의 추출방법, 췌장암 진단용 바이오마커 및 이를 이용한 췌장암의 진단 방법
WO2015121663A1 (en) Biomarkers for prostate cancer
AU2014202370B2 (en) Gene Expression Profiles to Predict Breast Cancer Outcomes
WO2019195935A1 (en) Methods for monitoring and treating prostate cancer

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20251117

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR